AN2 Therapeutics, Inc.

ANTX Nasdaq CIK: 0001880438

Company Information

Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 1300 EL CAMINO REAL, SUITE 100, MENLO PARK, CA, 94025
Mailing Address 1300 EL CAMINO REAL, SUITE 100, MENLO PARK, CA, 94025
Phone (650) 331-9090
Fiscal Year End 1231
EIN 820606654

Financial Overview

FY2025

-$35.17M
Net Income

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report March 23, 2026 View on SEC
4 Insider stock transaction report March 23, 2026 View on SEC
4 Insider stock transaction report March 23, 2026 View on SEC
4 Insider stock transaction report March 23, 2026 View on SEC
4 Insider stock transaction report March 23, 2026 View on SEC
4 Insider stock transaction report March 23, 2026 View on SEC
4 Insider stock transaction report March 23, 2026 View on SEC
4 Insider stock transaction report March 23, 2026 View on SEC
4 Insider stock transaction report March 23, 2026 View on SEC
4 Insider stock transaction report March 23, 2026 View on SEC

Insider Trading

SELL 5 insiders 9 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2834)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.